|
Canada-0-THREAD Azienda Directories
|
Azienda News:
- How Do I Report Hydration and Reclast® Infusion? - AAPC
Q: What is the proper CPT® coding for Reclast® infusion? Reclast® requires a 30-minute hydration prior to administration May we report this separately? A: Reclast® (zoledronic acid) is an infused medication used to treat osteoporosis and Paget’s disease of bone
- Billing and Coding: Bisphosphonate Drug Therapy
J3489 Zoledronic acid To report low bone mass for procedure code J3489 use diagnosis code M81 0 - Age-related osteoporosis without current pathological fracture
- Zoledronic acid: Zometa®; Reclast® - OHSU
Bhoopalam N, Campbell SC, Moritz T, et al Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy
- Zoledronic Acid - Medical Clinical Policy Bulletins | Aetna
Zoledronic acid 4 mg injection is considered experimental, investigational, or unproven for concurrent use with other zoledronic acid therapy formulations (e g , Reclast) or another bisphosphonate
- RECLAST J Code: J3489 | Cost and Price - buyandbill. com
According to CMS Drug Use Information: This medication is used to treat a certain type of bone disease (Paget's disease) that causes abnormal and weak bones Zoledronic acid is also used to treat bone loss (osteoporosis) in men and in women after menopause who are at high risk of having broken bones (fractures)
- Zoledronic Acid (Zometa - NantHealth
Note: Coverage of zoledronic acid will be provided for an FDA-approved indication or National Comprehensive Cancer Network (NCCN) guidelines when it is a Category 1, 2A, or 2B recommendation or when all criteria are met
- HCPCS Code J3489: How to Bill Recover Revenue - coding. health
While HCPCS Code J3489 is universally recognized, coverage policies for zoledronic acid can vary significantly among commercial insurers Providers should consult each payer’s specific policies regarding prior authorization and documentation requirements
- HCPCS Code J3489 (Reclast) - Description and Fee Schedule 2026 - PayerPrice
Bring your top codes (like HCPCS J3489) and we'll show you how you compare in 15 minutes or less Review description and fee schedules for HCPCS Code J3489 (Reclast), intended for Drugs Administered Other than Oral Method, and compare rates across different payers
- Reimbursement Policy Zoledronic Acid (Zometa® Reclast
cid, which is an inhibitor of osteoclastic bone resorption Zoledronic acid binds to the bone matrix, which decreases osteoclastic activity, prevents bone resorption and skeletal calcium releas
- J3489 Reimbursement Rate 2026 | MedFeeSchedule
Current 2026 Medicare pricing for HCPCS CPT code J3489 Check national averages, RVU breakdowns, and local payment adjustments
|
|